Clinerion adds 4.5m patients to recruitment platform

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/AdrianHancu)
(Image: iStock/AdrianHancu)

Related tags: Clinical trial, Contract research organization, Pharmaceutical industry

Başkent University’s hospital cluster has joined Clinerion’s Patient Recruitment System (PRS) Platform, expanding sponsor access to potential clinical trial participants.

Clinerion’s patient data services include data-assisted protocol optimization, site feasibility evaluation, and patient identification.

The Ankara, Turkey-based Başkent University has more than 1,500 beds and six general hospital locations throughout Turkey with a total of approximately 4.5m patients. It also has an additional eight Dialysis Centers.

Bariş Erdoğan, Ph.D., head of EEMEA region, Clinerion Turkey, told us that access to a new, large patient pool increases the probability of complete clinical trial recruitment.

The addition also expands Clinerion’s coverage throughout Turkey and provides pharmaceutical companies and contract research organizations (CROs) access to specialized researchers.

For example, Başkent has specialists on physical therapy and rehabilitation, psycho-social rehabilitation, and dialysis – ensuring that trials to be conducted in those areas will have excellent clinical support​,” said Erdoğan.

By setting up a technically advanced professional research center, clinical trial processes will be manageable and measurable. More clinical trials will be available to the site and it will become a center of attraction for global sponsors​,” he explained.

As previously reported​, the company has been expanding its services into countries in Eastern Europe, the Middle East, and Africa (EEMEA) following Erdoğan’s appointment as the new regional head earlier this year.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more